文献速递神经免疫认知障碍与痴呆

多发性硬化与临床孤立综合征30年临床和磁共振成像观察研究

A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes.
PubMed 文献 · Ann Neurol · 2019-11-22

107例有EDSS评分者中77例为多发性硬化,32例(42%)仍完全独立行走(EDSS≤3.5),26例(34%)为继发进展型且EDSS均>3.5,16例(20%)多发性硬化参与死亡。基线幕下病灶和1年时深部白质病灶是30年继发进展型多发性硬化的最强早期预测因素。

要点

  • 30年时多发性硬化患者结局分化明显,部分早期即累积显著残疾。
  • 基线幕下病灶和1年深部白质病灶可预测30年继发进展型多发性硬化。
  • 该队列多数未接受疾病修饰治疗,32例(42%)仍完全独立行走。

核心结论

  • 起病30年后, largely untreated队列中多发性硬化结局出现分化,部分患者早期累积显著残疾,另一些长期病程较有利。
  • 这些结局可部分由首次表现后1年内的影像学发现预测。

研究设计与样本

  • 多发性硬化按2010年McDonald标准定义。

主要发现

  • 107例有EDSS评分者中77例为多发性硬化,32例(42%)EDSS≤3.5且均为复发缓解型,3例(4%)为复发缓解型且EDSS>3.5,26例(34%)为继发进展型且EDSS均>3.5,16例(20%)多发性硬化参与死亡。
  • 多发性硬化患者中11例接受疾病修饰治疗。
  • 30年继发进展型多发性硬化的最强早期预测因素为基线幕下病灶和1年时深部白质病灶。

关键数值与推荐

  • 多发性硬化定义采用2010年McDonald标准。
  • 残疾评估采用EDSS,完全独立行走定义为EDSS≤3.5。

临床怎么用

  • 对临床孤立综合征患者,基线幕下病灶和1年深部白质病灶可提示30年继发进展型多发性硬化风险。
  • 长期随访中需关注早期残疾累积和疾病进展。

局限性

  • 队列多数未接受疾病修饰治疗,可能影响结局的普遍性。
  • 30年临床结局数据仅获得120例,存在失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Clinical outcomes in multiple sclerosis (MS) are highly variable. We aim to determine the long-term clinical outcomes in MS, and to identify early prognostic features of these outcomes. METHODS: One hundred thirty-two people presenting with a clinically isolated syndrome were prospectively recruited between 1984 and 1987, and followed up clinically and radiologically 1, 5, 10, 14, 20, and now 30 years later. All available notes and magnetic resonance imaging scans were reviewed, and MS was defined according to the 2010 McDonald criteria. RESULTS: Clinical outcome data were obtained in 120 participants at 30 years. Eighty were known to have developed MS by 30 years. Expanded Disability Status Scale (EDSS) scores were available in 107 participants, of whom 77 had MS; 32 (42%) remained fully ambulatory (EDSS scores ≤3.5), all of whom had relapsing-remitting MS (RRMS), 3 (4%) had RRMS and EDSS scores >3.5, 26 (34%) had secondary progressive MS (all had EDSS scores >3.5), and MS contributed to death in 16 (20%). Of those with MS, 11 received disease-modifying therapy. The strongest early predictors (within 5 years of presentation) of secondary progressive MS at 30 years were presence of baseline infratentorial lesions and deep white matter lesions at 1 year. INTERPRETATION: Thirty years after onset, in a largely untreated cohort, there was a divergence of MS outcomes; some people accrued substantial disability early on, whereas others ran a more favorable long-term course. These outcomes could, in part, be predicted by radiological findings from within 1 year of first presentation. ANN NEUROL 2020;87:63-74.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Chung KK, Altmann D, Barkhof F, et al. A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes. Ann Neurol. 2019. PMID: 31693200. doi:10.1002/ana.25637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。